Clinical Trials Logo

Clinical Trial Summary

Detection of early esophageal cancer in surrounding normal tissue can be challenging even for experienced examiners. The early detection is essential to determine the following treatment. Early stages of esophageal cancers can be treated by endoscopic resection whereas advanced neoplasia might lead to an Operation of the esophagus. Diagnosis is made usually by biopsies of suspicious lesions or untargeted quadrant biopsies. The electrical properties in inflammatory tissue and cancer can be sensed by electrical bioimpedance technique. The aim of this study is to compare the impedance probe with the histological result and to investigate the feasibility of the new technique in detection of esophageal cancer.


Clinical Trial Description

Detection of early esophageal cancer in surrounding normal tissue can be challenging even for experienced examiners. The early detection is essential to determine the following treatment. Early stages of esophageal cancers can be treated by endoscopic resection (ER) whereas advanced neoplasia might lead to esophagectomy. Diagnosis is made usually by biopsies of suspicious lesions or untargeted quadrant biopsies. The electrical properties in inflammatory tissue and dysplasia can be sensed by electrical bioimpedance technique. The aim of this study is to compare the impedance probe with the histological result and to investigate the feasibility of the new technique in detection of esophageal cancer. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04046601
Study type Interventional
Source Sana Klinikum Offenbach
Contact
Status Completed
Phase N/A
Start date October 9, 2019
Completion date February 15, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04984733 - Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer Phase 2
Completed NCT05088304 - GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Terminated NCT03108885 - Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Recruiting NCT04886635 - Surgery As Needed for Oesophageal Cancer - 2
Recruiting NCT03301493 - Genomic Testing and Resulting Medical Decisions
Completed NCT03032224 - Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal Cancer
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Recruiting NCT02017002 - Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer N/A
Recruiting NCT03274349 - Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma N/A
Recruiting NCT05830097 - A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT03619317 - Impact of Cancer Therapy on Myocardial Function in Patients With Esophagus Cancer
Withdrawn NCT02843750 - Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery N/A
Not yet recruiting NCT05041335 - Wet Heparinized Suction for Abdominal Cancer N/A
Recruiting NCT04258813 - Onco-primary Care Networking to Support TEAM-based Care N/A
Completed NCT03541629 - Audit of the Spanish EURECCA Esophagogastric Cancer Registry
Completed NCT03102229 - Real-time Activity Monitoring to Prevent Admissions During RadioTherapy N/A
Recruiting NCT00193817 - Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial Phase 3
Completed NCT00318903 - Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer Phase 2
Completed NCT03719716 - Early Support in Primary Care for People Starting Treatment for Cancer N/A